Dr. Royal is an anesthesiologist and pain specialist and most recently served as chief of clinical affairs at AcelRx. He has more than 20 years of drug development experience.
Sorrento Therapeutics is an oncology-driven company developing new treatments for cancer and associated pain.
More Articles on Anesthesia:
Crystal Clear Solutions Develops Anesthesia Guide App for Surgical Procedures
AllCare Clinical Associates Appoints Dr. Frank Sutton as Partner
University of Michigan Health Startup Receives FDA Clearance for Patient Monitoring Software
